Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Milestone Medical Inc. [Member]
Adjustments to reconcile net cash used in operating activities:
Equity loss (gain) on joint venture		$ 976,099
Milestone Education LLC [Member]
Adjustments to reconcile net cash used in operating activities:
Equity loss (gain) on joint venture		7,836
Milestone China [Member]
Adjustments to reconcile net cash used in operating activities:
Equity loss (gain) on joint venture	222,719	63,979
Net loss	(3,354,962)	(2,546,310)
Depreciation expense	46,177	13,930
Amortization of patents	35,707	34,647
Common stock and options for compensation, consulting and vendor services	784,480	391,844
Equity loss (gain) on joint venture	222,719	1,047,914
Changes in operating assets and liabilities:
Increase in accounts receivable	(789,418)	(93,620)
Increase in other receivable	(8,975)
Increase in inventories	(233,393)	(743,299)
(Increase) decrease to advances on contracts	117	(1,870)
(Increase) decrease to prepaid expenses and other current assets	(71,240)	(15,215)
Decrease (Increase)in other assets	5,975	(2,670)
Increase (decrease) in accounts payable	407,536	(657,989)
Increase in accrued expenses and other payables	(67,367)	162,551
Net cash used in operating activities	(3,022,644)	(2,410,087)
Cash flows from investing activities:
Notes receivable from Milestone Medical		(1,000,000)
Due from related party		(430,629)
Investment in Treasury Bills		(5,550,283)
Purchases of intangible assets	(15,616)
Purchases of property and equipment	(15,668)	(42,418)
Cash acquired from variable interest entity	26,925
Net cash used in investing activities	(4,359)	(7,023,330)
Cash flows from financing activities:
Proceeds from exercise of stock options		12,750
Net Proceeds on Private Placement Offering	2,000,000
Capital contribution from noncontrolling interest	16,346	500,000
Net cash provided by financing activities	2,016,346	512,750
Net decrease in cash and cash equivalents	(1,010,657)	(8,920,667)
Cash and cash equivalents at beginning of period	4,194,384	10,367,993
Cash and cash equivalents at end of period	3,183,727	1,447,326
Supplemental disclosure of cash flow information:
Net assets acquired from variable interest entity	6,307
Shares issued to employees in lieu of cash compensations		35,000
Shares issued to employees for bonus	339,549	100,000
Shares issued to consultants in lieu of cash payment	$ 75,000	$ 30,000